Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

252
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
252
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Migration to Emergency: A Systematic Review of Acute Presentations Following Late Esophageal Stent Migration.

Journal of clinical medicine·2026
Same author

Pattern of lymph node spread in gastric cancer: Western multicenter retrospective study.

BJS open·2026
Same author

Experimental Burn Induction in Laboratory Animals: A Scoping Review of Methods, Reproducibility, Operator-Dependent Variability, and Relevance to Soft Tissue Reconstruction and Repair.

Bioengineering (Basel, Switzerland)·2026
Same author

Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies.

Life (Basel, Switzerland)·2026
Same author

Impact of Gut Microbiota on the Clinical Course and Treatment Outcomes of Colorectal Cancer-A Systematic Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Burnout and Insomnia Among Greek Physicians Affiliated with the Athens Medical Association After the Acute Phase of the COVID-19 Pandemic: Prevalence and Contributing Factors.

Epidemiologia (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 16, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K

Hereditary Diffuse Gastric Cancer: A 2022 Update.

Christo Kole1, Nikolaos Charalampakis2, Stratigoula Sakellariou3

  • 1First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 115 27 Athens, Greece.

Journal of Personalized Medicine
|December 23, 2022
PubMed
Summary

Hereditary diffuse gastric cancer (HDGC) is a rare, inherited cancer linked to CDH1 gene mutations. This study reviews its molecular basis, genetic counseling, and clinical management guidelines for at-risk individuals and early-stage patients.

Keywords:
CDH1CTNNA1MAP3K6clinical guidelinesgastrectomyhereditary diffuse gastric cancer

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

819
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K

Related Experiment Videos

Last Updated: Aug 16, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

819
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Gastric cancer is a leading cause of cancer death globally.
  • Hereditary diffuse gastric cancer (HDGC) accounts for <1% of gastric cancers.
  • HDGC involves germline mutations in CDH1 or CTNNA1 genes, presenting as autosomal dominant inheritance.

Purpose of the Study:

  • To provide an overview of the molecular underpinnings of HDGC.
  • To outline essential components of genetic counseling and surveillance for HDGC.
  • To summarize current clinical management and treatment guidelines for individuals at risk and early-stage HDGC patients.

Main Methods:

  • Literature review on molecular basis of HDGC.
  • Synthesis of current genetic counseling and surveillance protocols.
  • Compilation of clinical management and treatment guidelines.

Main Results:

  • Detailed explanation of the molecular genetics of HDGC, focusing on CDH1 and CTNNA1.
  • Key elements for effective genetic counseling and surveillance strategies.
  • Practical summary of established guidelines for patient management.

Conclusions:

  • Understanding the molecular basis of HDGC is crucial for early detection and management.
  • Genetic counseling and surveillance are vital for individuals with hereditary risk.
  • Adherence to clinical guidelines ensures optimal treatment for HDGC patients.